Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: 4th edition

This document updates UK Haemophilia Centre Doctors Organization (UKHCDO) guidelines on the management of factor VIII/IX (FVIII/IX) inhibitors in congenital haemophilia (Hay et al, 2000, 2006). Acquired haemophilia is excluded and will be covered separately. Most data apply to FVIII inhibitors and the recommendations for FIX inhibitors are sometimes extrapolated from this.

British Journal of Haematology, 2013, 160, 153–170 , doi:10.1111/bjh.12091